GALT – galectin therapeutics inc. (US:NASDAQ)
Stock Stats
News
Galectin Therapeutics Inc. (NASDAQ: GALT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting [Yahoo! Finance]
Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
Galectin Therapeutics Inc. (NASDAQ: GALT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update [Yahoo! Finance]
Form 8-K GALECTIN THERAPEUTICS For: Nov 14
Form 8-K GALECTIN THERAPEUTICS For: Nov 14
Form 10-Q GALECTIN THERAPEUTICS For: Sep 30
Form 4 GALECTIN THERAPEUTICS For: Oct 23 Filed by: ELDRED KARY
Form 4 GALECTIN THERAPEUTICS For: Oct 17 Filed by: FREEMAN KEVIN D
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.